Headlands Research completes acquisition of Pharmasite Research, expanding expertise in mental health and CNS research
Headlands Research completes acquisition of Pharmasite Research, expanding expertise in mental health and CNS research
03/01/24, 7:37 AM
Location
Industry
healthcare
medical
biotechnology
Headlands Research, a multinational network of clinical trial sites, has completed the acquisition of Pharmasite Research, an established clinical trial site dedicated to research in mental illness and disorders of the central nervous system (CNS). This strategic acquisition enhances Headlands Research's therapeutic expertise in key competencies, reinforcing its commitment to advancing innovative medical therapies.
Company Info
Location
130 john f. kennedy dr.
Lake Worth, Florida, United States
Company info
Headlands Research is a multinational integrated clinical trial site organization with a mission to improve lives by advancing innovative medical therapies. Its group of exceptional sites focuses on large-volume recruitment of diverse and specialty patient populations while delivering the highest quality data. Headlands Research's principal investigators are proven industry leaders in their fields with expertise in a wide variety of indications. Utilizing expert recruitment strategies and access to diverse patients through its site databases and physician partnerships, Headlands Research has successfully completed more than 5,000 clinical trials.

Unlock Strategic Intelligence with Fundz
This is just a small preview. Unlock the full dataset of company insights, strategic events, and leadership shifts — all in one platform.
Trusted by sales, BD, and investment teams at Oracle, HubSpot, Affinity, and more.
Related people
AH
KH
Trends
Raised | Growth The data in the raised column shows reported funding for this location/industry over last 90 days. The data in the growth column indicates the % increase or decrease of the last 90 days vs. the previous 90 days. Please note: one or more large fundings, especially for a location/industry that doesn't historically receive much funding, can have a significant impact on the increase or decrease percentage. | |
---|---|---|
$62.1 M | -28.5% | |
biotechnology | $9.1 B | -20.1% |
medical | $1.6 B | 13.0% |
healthcare | $174.9 M | -76.5% |